Inoculum effect of methicillin-susceptible Staphylococcus aureus against broad-spectrum beta-lactam antibiotics
Scarce information concerning the inoculum effect (InE) of methicillin-susceptible Staphylococcus aureus (MSSA) against broad-spectrum β-lactam antibiotics is available. We investigated the InE of MSSA against ceftriaxone, cefepime, meropenem, ampicillin/sulbactam and piperacillin/tazobactam. The ba...
Gespeichert in:
Veröffentlicht in: | European journal of clinical microbiology & infectious diseases 2019-01, Vol.38 (1), p.67-74 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Scarce information concerning the inoculum effect (InE) of methicillin-susceptible
Staphylococcus aureus
(MSSA) against broad-spectrum β-lactam antibiotics is available. We investigated the InE of MSSA against ceftriaxone, cefepime, meropenem, ampicillin/sulbactam and piperacillin/tazobactam. The bacteraemic MSSA isolates were collected at ten Korean general hospitals from Sep 2013 to Mar 2015. The InE was defined if MICs of antibiotics at high inoculum (HI, ~5 × 10
7
CFU/ml) increased beyond the susceptible range compared to those at standard inoculum (SI, ~5 × 10
5
CFU/ml). All isolates were sequenced for
blaZ
gene typing. Among 302 MSSA isolates, 254 (84.1%) were positive for
blaZ
; types A, B, C and D were 13.6%, 26.8%, 43.4% and 0.3%, respectively. Mean HI MICs of all tested antibiotics were significantly increased and increases in HI MIC of piperacillin/tazobactam (HI, 48.14 ± 4.08 vs. SI, 2.04 ± 0.08 mg/L,
p
|
---|---|
ISSN: | 0934-9723 1435-4373 |
DOI: | 10.1007/s10096-018-3392-6 |